Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Its clinical development for obesity was discontinued in 2007 after the pivotal 536-participant Phase IIb trial failed to meet its primary efficacy endpoint, and no formulation of the compound has received FDA approval since
I just received my 2nd bottle
AOD-9604 and Metabolic Health Research has shown that AOD-9604 can influence lipid metabolism in several ways
As a certified national high-tech enterprise, we speciaize in end-to-end services encompassing pharmaceutical active ingredients(apis), advanced intermediates, bioactive compounds, peptide therapeutics, veterinary pharmaceuticals, and speciaty chemical reagents, while pioneeringbreakthrouohs in cosmetic functional ingredients and novel health ...
US$ 20.34
US$ 26.99
US$ 21.31
US$ 24.31
US$ 27.17
US$ 20.39
US$ 22.31
